← Back to Search

Exercise Training Program for Multiple Sclerosis (TEAAMS Trial)

N/A
Recruiting
Led By Robert W Motl, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of MS
Age of 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes in walking scores from baseline, 4-months, and 8-months.
Awards & highlights

TEAAMS Trial Summary

This trial will test if a remotely-delivered, racially-tailored exercise training program can improve walking dysfunction, symptoms, and health-related quality of life for African-Americans with MS who live in rural areas.

Who is the study for?
This trial is for African-American adults with Multiple Sclerosis living in rural areas, who are not very active physically, can use the internet and email, speak English, have been relapse-free for 30 days, and have mild to moderate walking difficulties. It's not for those at high risk of injury or death from intense exercise.Check my eligibility
What is being tested?
The study tests a remote exercise program tailored for African-Americans with MS against a control group doing stretching exercises. The goal is to see if the program improves walking ability, symptoms, and quality of life immediately and over four months.See study design
What are the potential side effects?
Since this trial involves an exercise program and stretching routines rather than medication or invasive procedures, side effects may include typical exercise-related issues such as muscle soreness or strain.

TEAAMS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with multiple sclerosis (MS).
Select...
I am 18 years old or older.

TEAAMS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes in walking scores from baseline, 4-months, and 8-months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes in walking scores from baseline, 4-months, and 8-months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Walking Dysfunction
Secondary outcome measures
Anxiety
Depressive Symptoms
Disability
+2 more
Other outcome measures
Exercise Behavior

TEAAMS Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Guidelines for Exercise in Multiple Sclerosis (GEMS)Experimental Treatment1 Intervention
Participants in this condition will receive a 4-month home-based, remotely supported aerobic and resistance exercise program based on the Guidelines for Exercise in Multiple Sclerosis (GEMS).
Group II: FLEX Stretching and Toning ProgramPlacebo Group1 Intervention
Participants in this condition will receive a 4-month home-based, remotely supported stretching program emphasizing flexibility and range of motion as important components of fitness based on Stretching for People with MS: An Illustrated Manual from the National MS Society.

Find a Location

Who is running the clinical trial?

Bristol-Myers SquibbIndustry Sponsor
2,631 Previous Clinical Trials
4,126,572 Total Patients Enrolled
13 Trials studying Multiple Sclerosis
22,184 Patients Enrolled for Multiple Sclerosis
University of Alabama at BirminghamOTHER
1,571 Previous Clinical Trials
2,268,911 Total Patients Enrolled
37 Trials studying Multiple Sclerosis
45,183 Patients Enrolled for Multiple Sclerosis
University of Illinois at ChicagoLead Sponsor
604 Previous Clinical Trials
1,558,495 Total Patients Enrolled
11 Trials studying Multiple Sclerosis
1,436 Patients Enrolled for Multiple Sclerosis

Media Library

Guidelines for Exercise in Multiple Sclerosis (GEMS) Clinical Trial Eligibility Overview. Trial Name: NCT05516537 — N/A
Multiple Sclerosis Research Study Groups: FLEX Stretching and Toning Program, Guidelines for Exercise in Multiple Sclerosis (GEMS)
Multiple Sclerosis Clinical Trial 2023: Guidelines for Exercise in Multiple Sclerosis (GEMS) Highlights & Side Effects. Trial Name: NCT05516537 — N/A
Guidelines for Exercise in Multiple Sclerosis (GEMS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05516537 — N/A
Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT05516537 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you inform me if enrollment is open for this clinical trial?

"Indeed, clinicaltrials.gov reveals that this research initiative is currently attempting to enrol patients. This experiment was launched September 2nd 2022 and its most recent update took place on October 31st 2022. At the moment, 100 individuals are needed at a single medical facility."

Answered by AI

What is the sample size for this experiment?

"Affirmative. The clinical trial's page on clinicaltrials.gov affirms that it is currently enrolling patients; the study was posted to the website on September 2nd, 2022 and has been modified as recently as October 31st, 2022. Currently, they are recruiting 100 participants from 1 medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Mississippi
New York
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
3+
What site did they apply to?
University of Illinois at Chicago

Why did patients apply to this trial?

to support research and MS trials. I am looking for trials that specifically address MS and trials that can help/alleviate symptoms or therapy to repair damaged axons(demyelination).
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Phone Call
Email
~18 spots leftby Aug 2024